Literature DB >> 15583831

Interleukin-1beta and tumor necrosis factor-alpha upregulate interleukin-23 subunit p19 gene expression in human colonic subepithelial myofibroblasts.

Zhuobin Zhang1, Akira Andoh, Hirofumi Yasui, Osamu Inatomi, Kazunori Hata, Tomoyuki Tsujikawa, Katsuyuki Kitoh, Atsushi Takayanagi, Nobuyoshi Shimizu, Yoshihide Fujiyama.   

Abstract

The recently identified cytokine interleukin-23 (IL-23) consists of p19 and p40 subunits. The major cellular source of IL-23 is dendritic cells and/or macrophages. We investigated the expression of IL-23 p19 mRNA in human colonic subepithelial myofibroblasts (SEMFs). p19 mRNA was not expressed in unstimulated SEMFs, but IL-1beta and TNF-alpha strongly induced p19 mRNA expression in these cells. The effects of IL-1beta were much stronger than those of TNF-alpha. These responses were observed in both a dose- and time-dependent manner. Furthermore, these cytokines acted synergistically when used in combination. A blockade of NF-kappaB activation by the overexpression of a stable form of IkappaBalpha completely blocked these responses, indicating that the induction of p19 mRNA expression by IL-1beta and TNF-alpha was mediated by the NF-kappaB activation pathway. In conclusion, this is the first report demonstrating that IL-23 p19 mRNA is inducible in colonic myofibroblasts by IL-1beta and TNF-alpha. The p19 expression in these cells might play a role in mucosal immune responses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15583831

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  6 in total

Review 1.  Interleukin-23 as a potential therapeutic target for rheumatoid arthritis.

Authors:  Chao Rong; Wei Hu; Fan-rong Wu; Xiao-juan Cao; Fei-hu Chen
Journal:  Mol Cell Biochem       Date:  2011-10-20       Impact factor: 3.396

2.  Induction of interleukin-23 p19 by serum amyloid A (SAA) in rheumatoid synoviocytes.

Authors:  K Migita; T Koga; T Torigoshi; S Motokawa; Y Maeda; Y Jiuchi; Y Izumi; T Miyashita; M Nakamura; A Komori; H Ishibashi
Journal:  Clin Exp Immunol       Date:  2010-09-14       Impact factor: 4.330

3.  Treatment of murine Th1- and Th2-mediated inflammatory bowel disease with NF-kappa B decoy oligonucleotides.

Authors:  Stefan Fichtner-Feigl; Ivan J Fuss; Jan C Preiss; Warren Strober; Atsushi Kitani
Journal:  J Clin Invest       Date:  2005-10-20       Impact factor: 14.808

4.  Effects of oral commensal and pathogenic bacteria on human dendritic cells.

Authors:  T Chino; D M Santer; D Giordano; C Chen; C Li; C-H Chen; R P Darveau; E A Clark
Journal:  Oral Microbiol Immunol       Date:  2009-04

5.  Protective effects of dietary curcumin in mouse model of chemically induced colitis are strain dependent.

Authors:  Claire Billerey-Larmonier; Jennifer K Uno; Nicolas Larmonier; Anna J Midura; Barbara Timmermann; Fayez K Ghishan; Pawel R Kiela
Journal:  Inflamm Bowel Dis       Date:  2008-06       Impact factor: 5.325

6.  Lactobacillus acidophilus suppresses colitis-associated activation of the IL-23/Th17 axis.

Authors:  Linlin Chen; Yiyou Zou; Jie Peng; Fanggen Lu; Yani Yin; Fujun Li; Junwen Yang
Journal:  J Immunol Res       Date:  2015-04-20       Impact factor: 4.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.